RESCUE and REVERSE Long-term Follow-up

Clinical trial NCT03406104 · COMPLETED

Trial details

NCT number: NCT03406104
Sponsor: GenSight Biologics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Leber Hereditary Optic Neuropathy

Start date: 2018-01-09
Primary completion: 2022-07-04
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.